*Drs. Hagen and Sorah were enrolled in the pharmacy professional program during conduction of this study. 
Introduction
The United States Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) defines a practice-based research network (PBRN) as a "group of ambulatory practices devoted principally to the primary care of patients, and affiliated in their mission to investigate questions related to community-based practice and to
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The Appalachian Research Network (AppNET), a family medicine PBRN, was established in 2009 by the East Tennessee State University (ETSU) Department of Family Medicine. Funding for AppNET was first provided by the Health Resources and Services Administration (HRSA) through a mechanism designed to grow PBRN resources in underserved areas (Grant # D54HP20673). AppNET's mission is to conduct and support practice-based research to improve the quality of rural primary care delivered in the region, and work toward the goal of eliminating health disparities in South Central Appalachia. AppNET research efforts to date have focused in the areas of electronic health record clinicbased quality improvement and prescription drug abuserelated perceptions of clinicians; two topics that are applicable to and could be of interest to community pharmacists.
AppNET is comprised of 17 family medicine clinics in 16 rural Northeast Tennessee, Southwest Virginia, and Western North Carolina communities. Several AppNET counties are designated as distressed or at risk by the Appalachian Regional Commission (ARC). 8 This area of Appalachia has a higher rate of chronic disease and a higher proportion of individuals with disabilities compared to the nation as a whole and exceeds the national death rate for heart disease, cancer, stroke, diabetes, and chronic obstructive pulmonary disease. 9 Moreover, the area is comprised of many rural counties with designated medically underserved areas/populations and primary care health professions shortage areas. 8, 10 Pharmacists are accessible health care providers in many rural communities and are a logical cohort to engage in rural interprofessional research. The role of community pharmacies in the delivery of health care in rural settings is well established. [11] [12] [13] [14] [15] Rural pharmacists not only provide prescription dispensing services but also provide many nondispensing services such as immunizations, disease state management, medication therapy management (MTM), and services to local community health care organizations (e.g., long-term care facilities). 16, 17 Recent methodologically rigorous research highlights positive patient outcomes achieved through community pharmacist patient care activities. [18] [19] [20] An 23 Barriers to PBRN participation commonly mentioned by pharmacists in these studies included time constraints, lack of research experience, and a lack of funding to conduct research.
21,22,24
The objectives of this study were to: 1) evaluate rural Appalachian community pharmacy key informants' perceptions of PBRNs and practice-based research; 2) explore key informants' perceptions of perceived applicability of practice-based research domains; and 3) explore interest in AppNET participation among community pharmacy key informants.
To our knowledge this is the first study that examines perceptions of feasibility and need for integration of community pharmacies, essential service providers in rural settings, into an interprofessional, rural PBRN.
Methods

Sample
State-specific health professions licensing directories and web search tools were used to identify all pharmacies within the city limits of communities containing at least one AppNETaffiliated clinic. Two research assistants independently compiled community pharmacy information to ensure the sampling frame was complete. A total of 67 operational community pharmacies comprised the sampling frame. Researchers contacted each community pharmacy via telephone to describe the study and obtain contact information for one key informant at each pharmacy.
Key informants were recruited in three waves across a 3-month timeframe. The first and second paper-based survey mailings were separated by 14 days. Each mailing included a personalized cover letter, a brief description of PBRNs as
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defined by AHRQ and a brief description of the AppNET PBRN. In addition to the survey instrument, the mailings also included a one-page frequently asked questions and answers document about PBRNs and a stamped return envelope. Approximately 90 days after the second paper-based mailing was sent, non-respondents received a follow-up phone call from the researchers to tailor the delivery mechanism (e.g., facsimile, email, mail) of the third request for study participation. A third request was made thereafter that was specific to contact preferences. The follow-up phone call and subsequent survey instrument delivery were delayed in order to obtain an IRB modification to the study protocol and thereafter minimize non-response that might be associated with end-of-year holidays and beginning-of-year pharmacy volume. No incentive was provided to key informants for study participation.
Instrumentation
Guided by previously published pharmacy-specific survey instruments, 21,22 a 3-page, 50-item survey instrument was developed to capture information across five domains: 1) key informant and pharmacy demographic characteristics (e.g., age, gender, years licensed, weekly prescription volume); 2) service provision status within the key informant's pharmacy (e.g., compounding, health screenings, immunizations, MTM); 3) perceptions of research conduction in a community pharmacy; 4) benefits of and barriers to participation in a PBRN; and 5) overall interest in PBRN participation. The survey instrument included items that elicited perceptions about interest in health information technology (HIT) and prescription drug abuse research; two topics of interest to PBRN researchers and clinicians. Five community pharmacists pilot tested survey instrument items for clarity and relevance. Minor wording changes and addition of research domains resulted from pilot testing. Key informants responded to survey items using constructed response, categorical, and 5-point Likert response scales. The survey instrument is provided in Appendix 1. (Table 4) . Independent pharmacy key informants indicated that health information technology research (p = 0.008) and reimbursement/third party research (p = 0.028) were more applicable to their settings as compared to key informants working in other pharmacy settings. No other differences in research applicability were noted across respondent or practice setting characteristics.
Statistical Analysis
Enrichment of patient care (82.8%), improved relationships with providers in the community (75.9%), and professional development opportunities (69.0%) were perceived by more than two-thirds of respondents to be very beneficial outcomes of PBRN participation (Table 4 ). Independent pharmacy respondents perceived an enhanced relationship with the study institution to be a more beneficial outcome as compared to respondents in other practice settings (p = 0.041). No other differences in perceived PBRN participation benefits were noted across respondent or practice setting characteristics.
Discussion
To our knowledge, this is the first study to explore feasibility of PBRN participation in rural community pharmacies and integration of community pharmacies into an already established rural PBRN. Similar to the Carr et al. and Seel et al. studies, we found that most pharmacy key informants were somewhat or very interested in participating in a PBRN. 21, 22 However, we also noted that nearly three-fourths of respondents indicated they lacked sufficient knowledge about PBRNs to make an informed decision whether or not their pharmacy's participation in a PBRN is a good idea. This finding perhaps highlights the gap between research and practice and the complexity inherent in evaluating opportunity costs/gains associated with patient care and business/practice decisions. Many respondents felt that PBRN participation would improve patient care and improve their professional relationships within the community. Considering obstacles faced by rural pharmacies, and independent pharmacies in particular, the dissonance in wanting to improve patient care and wanting to participate in the PBRN, but being cautious in decision-making is perhaps to be expected. 13 Respondents indicated time constraints and workflow interruptions were the biggest barriers to PBRN participation. Whereas time commitment and workflow disruption could be considered project dependent, research is warranted to quantify the return on investment, or lack thereof, associated with PBRN participation, including intangible factors that are difficult to assess (e.g., patient care enrichment, pharmacy-prescriber relationships). Overall, increased information about PBRNs and the potential costs and benefits resulting from participation from the community pharmacy perspective are needed based on key informant responses.
Carr et al noted that over 95% of surveyed pharmacists perceived compensation to be necessary for PBRN participation. 21 Exploration of financial incentives necessary for participating in AppNET was not examined directly in our study, but nearly two-thirds of respondents indicated increased revenue as a very beneficial aspect of PBRN participation. Considering that a large percentage of respondents represented rural independent pharmacies, particular attention should be given to beneficial financial outcomes of PBRN participation, including potential revenue increases (e.g., revenues associated with implementation of study-supported services, increases in prescription volume associated with medication adherence projects) and financial incentives for participation.
More than 90% of key informants indicated all proposed research domains were somewhat or very applicable to their practices. Importantly, several of the domains included in the survey instrument were directly applicable to improving health outcomes in the region. For example, medication adherence research and improvement could positively impact multiple disease states, including cardiovascular disease, diabetes, chronic obstructive pulmonary disease, and other ambulatory care sensitive conditions that are prevalent in rural Appalachia and likely managed by primary care providers within AppNET communities. 25 As pharmacies are recruited to AppNET membership, the potential resources that PBRN staff, including practice enhancement assistants, could provide to members should also be considered. Research domains of interest to key informants, in particular, could guide resource development. Our interprofessional research specific to prescription drug abuse within AppNET communities supports the need for resource development and dissemination. To our knowledge, current pharmacy-specific PBRNs do not emphasize resource provision to their members.
Recruitment of community pharmacies into AppNET will create a unique, interprofessional PBRN. The rural, underserved environment in which study pharmacies are located, geographic distance between communities, and geographic distance of pharmacies from the research institution will create challenges in integrating community pharmacies into AppNET. Yet, AppNET expansion, and integration of community pharmacies in to primary care PBRNs generally, presents an opportunity to conduct multifaceted, interdisciplinary research to solve communityspecific health problems and promote evidence-based interprofessional patient care. Rural and underserved communities could realize increased return on investment through resource sharing and interprofessional, communitybased research collaboration associated with PBRN participation. Further research is warranted to develop PBRN enrollment mechanisms that minimize barriers to participation of community pharmacies in practice-based research.
Limitations
There are several limitations to our study that deserve mention. First, after employing three recruitment waves, including one telephone call to community pharmacies, a response rate of 47.8% was obtained. It is hypothesized that non-responders would be more likely to be uninterested in PBRN participation as compared to respondents. However, non-response bias analyses indicated no statistically significant differences in PBRN interest between key informants who responded to the first wave and those who responded to subsequent contact attempts. Overall, a larger percentage of independent pharmacy key informants participated in the study as compared to key informants in non-independently owned pharmacies (60% vs. 38%). However, no differences were noted in practice setting characteristics across early and late responders. Our small sample size also limits statistical power to detect a difference where differences in perceptions indeed exist. The extent to which the key informant who responded to the survey has the ability to make the decision to participate in AppNET is unknown. In particular, respondents who are employed in non-independently owned pharmacies may have limited influence on participation. Finally, the potential for social desirability bias should be considered as the respondents were aware the team administering the survey instrument was research-focused.
Conclusion
A large majority of key informants in rural Appalachian community pharmacies indicated interest in participating in an established primary care PBRN. Respondents noted several positive perceptions of PBRN participation, including improved quality of patient care, and improved employee perceptions of their work. Multiple research domains were of interest, including projects currently being conducted with AppNET prescribers, and multiple perceived benefits of PBRN participation were noted. The interest in AppNET expressed by community pharmacists is an exciting first step towards integrating this cohort into the PBRN. Ultimately, the development of PBRNs that include and employ community pharmacies could positively advance community level care coordination and promote improved health outcomes in rural and underserved areas. 
